The action of CGRP and SP on cultured skin fibroblasts

[1] Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol. 1998; 30:5–11. http://dx.doi.org/10.1016/S0306-3623(97)00078-510.1016/S0306-3623(97)00078-5Search in Google Scholar

[2] Rossi R, Johansson O. Cutaneous innervation and the role of neuronal peptides in cutaneous inflammation: a minireview. Eur J Dermatol. 1998; 8:299–306. Search in Google Scholar

[3] Watson RE, Supowit SC, Zhao H, Katki KA, Dipette DJ. Role of sensory nervous system vasoactive peptides in hypertension. Braz J Med Biol Res. 2002; 35:1033–1045. http://dx.doi.org/10.1590/S0100-879X200200090000410.1590/S0100-879X2002000900004Search in Google Scholar

[4] Petersen LJ, Church MK, Skov PS. Histamine is released in the wheal but not the flare following challenge of human skin in vivo: a microdialysis study. Clin Exp Allergy. 1997; 27:284–295. http://dx.doi.org/10.1046/j.1365-2222.1997.d01-502.x10.1111/j.1365-2222.1997.tb00707.xSearch in Google Scholar

[5] Weidner C, Klede M, Rukwied R, Lischetzki G, Neisius U, Skov PS, Petersen LJ, Schmelz M. Acute effects of substance P and calcitonin generelated peptide in human skin—a microdialysis study. J Invest Dermatol. 2000; 115:1015–1020. http://dx.doi.org/10.1046/j.1523-1747.2000.00142.x10.1046/j.1523-1747.2000.00142.xSearch in Google Scholar

[6] Toyoda M, Morohashi M. New aspects in acne inflammation. Dermatology. 2003; 206:17–23. http://dx.doi.org/10.1159/00006781810.1159/000067818Search in Google Scholar

[7] Steinhoff M, Ständer S, Seeliger S, Ansel JC, Schmelz M, Luger T. Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol. 2003; 139:1479–1488. http://dx.doi.org/10.1001/archderm.139.11.147910.1001/archderm.139.11.1479Search in Google Scholar

[8] Esteves Junior I, Ferreira LM, Liebano RE. Peptídeo relacionado ao gene da calcitonina por iontoforese na viabilidade de retalho cutâneo randômico em ratos [Calcitonin gene-related peptide by iontophoresis on the viability of the randon skin flaps in rats]. Acta Cir Bras. 2004; 19:626–629. http://dx.doi.org/10.1590/S0102-8650200400060000810.1590/S0102-86502004000600008Search in Google Scholar

[9] Lotti T, Hautmann G, Panconesi E. Neuropeptides in skin. J Am Acad Dermatol. 1995; 33:482–496. http://dx.doi.org/10.1016/0190-9622(95)91395-510.1016/0190-9622(95)91395-5Search in Google Scholar

[10] Hagner S, Haberberger RV, Overkamp D, Hoffmann R, Voigt KH, McGregor GP. Expression and distribution of calcitonin receptor-like receptor in human hairy skin. Peptides. 2002; 23:109–116. http://dx.doi.org/10.1016/S0196-9781(01)00586-110.1016/S0196-9781(01)00586-1Search in Google Scholar

[11] Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 1982; 298:240–244. http://dx.doi.org/10.1038/298240a010.1038/298240a0Search in Google Scholar PubMed

[12] Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature. 1983; 304:129–135. http://dx.doi.org/10.1038/304129a010.1038/304129a0Search in Google Scholar

[13] Amara SG, Evans RM, Rosenfeld MG. Calcitonin/calcitonin gene-related peptide transcription unit: tissue-specific expression involves selective use of alternative polyadenylation sites. Mol Cell Biol. 1984; 4:2151–2160. Search in Google Scholar

[14] Goodman EC, Iversen LL. Calcitonin gene-related peptide: novel neuropeptide. Life Sci. 1986; 38:2169–2178. http://dx.doi.org/10.1016/0024-3205(86)90568-010.1016/0024-3205(86)90568-0Search in Google Scholar

[15] Breimer LH, MacIntyre I, Zaidi M. Peptides from the calcitonin genes: molecular genetics, structure and function. Biochem J. 1988; 255:377–390. 10.1042/bj2550377Search in Google Scholar

[16] Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev. 2004; 84:903–934. http://dx.doi.org/10.1152/physrev.00037.200310.1152/physrev.00037.2003Search in Google Scholar

[17] Peters EM, Ericson ME, Hosoi J, Seiffert K, Hordinsky MK, Ansel JC, Paus R, Scholzen TE. Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol. 2006; 126:1937–1947. http://dx.doi.org/10.1038/sj.jid.570042910.1038/sj.jid.5700429Search in Google Scholar

[18] Kakizoe E, Kobayashi Y, Gonda T, Shimoura K, Hattori K, Okunishi H. Synergistic interactions between neuropeptide and histamine on the capillary permeability in rat skin: evaluation by reflectance spectrophotometry. Microvasc Res. 1997; 54:27–34. http://dx.doi.org/10.1006/mvre.1997.201710.1006/mvre.1997.2017Search in Google Scholar

[19] Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev. 2000; 21:457–487. 10.1210/er.21.5.457Search in Google Scholar

[20] Sleijffers A, Herreilers M, van Loveren H, Garssen J. Ultraviolet B radiation induces upregulation of calcitonin gene-related peptide levels in human Finn chamber skin samples. J Photochem Photobiol B. 2003; 69:149–152. http://dx.doi.org/10.1016/S1011-1344(03)00002-210.1016/S1011-1344(03)00002-2Search in Google Scholar

[21] Seiffert K, Granstein RD. Neuropeptides and neuroendocrine hormones in ultraviolet radiationinduced immunosuppression. Methods. 2002; 28:97–103. http://dx.doi.org/10.1016/S1046-2023(02)00214-110.1016/S1046-2023(02)00214-1Search in Google Scholar

[22] Seike M, Ikeda M, Morimoto A, Matsumoto M, Kodama H. Increased synthesis of calcitonin generelated peptide stimulates keratinocyte proliferation in murine UVB-irradiated skin. J Dermatol Sci. 2002; 28:135–143. http://dx.doi.org/10.1016/S0923-1811(01)00155-410.1016/S0923-1811(01)00155-4Search in Google Scholar

[23] Sakuta H, Inaba K, Muramatsu S. Calcitonin generelated peptide enhances cytokine-induced IL-6 production by fibroblasts. Cell Immunol. 1995; 165(1):20–25. http://dx.doi.org/10.1006/cimm.1995.118210.1006/cimm.1995.1182Search in Google Scholar

[24] V Euler US, Gaddum JH. An unidentified depressor substance in certain tissue extracts. J Physiol. 1931;72(1):74–87. 10.1113/jphysiol.1931.sp002763Search in Google Scholar

[25] Johansson A, Holmgren S, Conlon JM. The primary structures and myotropic activities of two tachykinins isolated from the African clawed frog, Xenopus laevis. Regul Pept. 2002; 108:113–121. http://dx.doi.org/10.1016/S0167-0115(02)00154-410.1016/S0167-0115(02)00154-4Search in Google Scholar

[26] Patacchini R, Lecci A, Holzer P, Maggi CA. Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature. Trends Pharmacol Sci. 2004; 25:1–3. http://dx.doi.org/10.1016/j.tips.2003.11.00510.1016/j.tips.2003.11.005Search in Google Scholar PubMed

[27] Nawa H, Kotani H, Nakanishi S. Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature. 1984; 312:729–734. http://dx.doi.org/10.1038/312729a010.1038/312729a0Search in Google Scholar PubMed

[28] Schmelz M, Petersen LJ. Neurogenic inflammation in human and rodent skin. News Physiol Sci. 2001; 16:33–37. 10.1152/physiologyonline.2001.16.1.33Search in Google Scholar PubMed

[29] Cappugi P, Tsampau D, Lotti T. Substance P provokes cutaneous erythema and edema through a histamine-independent pathway. Int J Dermatol. 1992; 31:206–209. http://dx.doi.org/10.1111/j.1365-4362.1992.tb03938.x10.1111/j.1365-4362.1992.tb03938.xSearch in Google Scholar PubMed

[30] Nilsson J, von Euler AM, Dalsgaard CJ. Stimulation of connective tissue cell growth by substance P and substance K. Nature. 1985; 315:61–63. http://dx.doi.org/10.1038/315061a010.1038/315061a0Search in Google Scholar PubMed

[31] Tanaka T, Danno K, Ikai K, Imamura S. Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol. 1988; 90:399–401. http://dx.doi.org/10.1111/1523-1747.ep1245648710.1111/1523-1747.ep12456487Search in Google Scholar PubMed

[32] Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol. 1998; 7:81–96. http://dx.doi.org/10.1111/j.1600-0625.1998.tb00307.x10.1111/j.1600-0625.1998.tb00307.xSearch in Google Scholar PubMed

[33] Okabe T, Hide M, Koro O, Yamamoto S. Substance P induces tumor necrosis factor-alpha release from human skin via mitogen-activated protein kinase. Eur J Pharmacol. 2000; 398:309–315. http://dx.doi.org/10.1016/S0014-2999(00)00304-610.1016/S0014-2999(00)00304-6Search in Google Scholar

[34] Takahashi K, Nakanishi S, Imamura S. Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors. J Invest Dermatol. 1993; 101:646–651. http://dx.doi.org/10.1111/1523-1747.ep1237167010.1111/1523-1747.ep12371670Search in Google Scholar

[35] Kakurai M, Fujita N, Kiyosawa T, Inoue T, Ishibashi S, Furukawa Y, Demitsu T, Nakagawa H. Vasoactive intestinal peptide and cytokines enhance stem cell factor production from epidermal keratinocytes DJM-1. J Invest Dermatol. 2002; 119:1183–1188. http://dx.doi.org/10.1046/j.1523-1747.2002.19506.x10.1046/j.1523-1747.2002.19506.xSearch in Google Scholar

[36] Albertin G, Carraro G, Parnigotto PP, Conconi MT, Ziolkowska A, Malendowicz LK, Nussdorfer GG. Human skin keratinocytes and fibroblasts express adrenomedullin and its receptors, and adrenomedullin enhances their growth in vitro by stimulating proliferation and inhibiting apoptosis. Int J Mol Med. 2003; 11:635–639. 10.3892/ijmm.11.5.635Search in Google Scholar

[37] Yule KA, White SR. Migration of 3T3 and lung fibroblasts in response to calcitonin gene-related peptide and bombesin. Exp Lung Res. 1999; 25(3):261–273. http://dx.doi.org/10.1080/01902149927030310.1080/019021499270303Search in Google Scholar

[38] Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience. 1992; 49:693–698. http://dx.doi.org/10.1016/0306-4522(92)90237-V10.1016/0306-4522(92)90237-VSearch in Google Scholar

[39] Amann R, Sirinathsinghji DJ, Donnerer J, Liebmann I, Schuligoi R. Stimulation by nerve growth factor of neuropeptide synthesis in the adult rat in vivo: bilateral response to unilateral intraplantar injections. Neurosci Lett. 1996; 203:171–174. http://dx.doi.org/10.1016/0304-3940(95)12287-710.1016/0304-3940(95)12287-7Search in Google Scholar

[40] Amann R, Egger T, Schuligoi R. The tachykinin NK(1) receptor antagonist SR140333 prevents the increase of nerve growth factor in rat paw skin induced by substance P or neurogenic inflammation. Neuroscience. 2000; 100:611–615. http://dx.doi.org/10.1016/S0306-4522(00)00315-810.1016/S0306-4522(00)00315-8Search in Google Scholar

[41] Wallengren J. Vasoactive peptides in the skin. J Investig Dermatol Symp Proc. 1997; 2:49–55. http://dx.doi.org/10.1038/jidsymp.1997.1110.1038/jidsymp.1997.11Search in Google Scholar PubMed

[42] Wu H, Guan C, Qin X, Xiang Y, Qi M, Luo Z, Zhang C. Upregulation of substance P receptor expression by calcitonin gene-related peptide, a possible cooperative action of two neuropeptides involved in airway inflammation. Pulm Pharmacol Ther. 2007; 20:513–524. http://dx.doi.org/10.1016/j.pupt.2006.04.00210.1016/j.pupt.2006.04.002Search in Google Scholar PubMed

[43] Baluk P. Neurogenic inflammation in skin and airways. J Investig Dermatol Symp Proc. 1997; 2:76–81. http://dx.doi.org/10.1038/jidsymp.1997.1510.1038/jidsymp.1997.15Search in Google Scholar

[44] Sauerstein K, Klede M, Hilliges M, Schmelz M. Electrically evoked neuropeptide release and neurogenic inflammation differ between rat and human skin. J Physiol. 2000; 529:803–810. http://dx.doi.org/10.1111/j.1469-7793.2000.00803.x10.1111/j.1469-7793.2000.00803.xSearch in Google Scholar

[45] Akaishi S, Ogawa R, Hyakusoku H. Keloid and hypertrophic scar: neurogenic inflammation hypotheses. Med Hypotheses. 2008; 71:32–38. http://dx.doi.org/10.1016/j.mehy.2008.01.03210.1016/j.mehy.2008.01.032Search in Google Scholar

[46] Hochman B, Nahas FX, Sobral CS, Arias V, Locali RF, Juliano Y, Ferreira LM. Nerve fibres: a possible role in keloid pathogenesis. Br J Dermatol. 2008; 158:651–652. http://dx.doi.org/10.1111/j.1365-2133.2007.08401.x10.1111/j.1365-2133.2007.08401.xSearch in Google Scholar

[47] Ferreira LM, Gragnani A, Furtado F, Hochman B. Control of the skin scarring response. An Acad Bras Cienc. 2009; 81:623–629. http://dx.doi.org/10.1590/S0001-3765200900030002410.1590/S0001-37652009000300024Search in Google Scholar

[48] Stelnicki EJ, Doolabh V, Lee S, Levis C, Baumann FG, Longaker MT, Mackinnon S. Nerve dependency in scarless fetal wound healing. Plast Reconstr Surg. 2000; 105:140–147. http://dx.doi.org/10.1097/00006534-200001000-0002410.1097/00006534-200001000-00024Search in Google Scholar

[49] Tucci-Viegas VM, Hochman B, Franca JP, Ferreira LM. Keloid explant culture: a model for keloid fibroblasts isolation and cultivation based on the biological differences of its specific regions. Int Wound J. 2010; 7:339–348. http://dx.doi.org/10.1111/j.1742-481X.2010.00698.x10.1111/j.1742-481X.2010.00698.xSearch in Google Scholar

[50] Kiss M, Kemény L, Gyulai R, Michel G, Husz S, Kovács R, Dobozy A, Ruzicka T. Effects of the neuropeptides substance P, calcitonin gene-related peptide and alpha-melanocyte-stimulating hormone on the IL-8/IL-8 receptor system in a cultured human keratinocyte cell line and dermal fibroblasts. Inflammation. 1999; 23:557–567. http://dx.doi.org/10.1023/A:102029450776710.1023/A:1020294507767Search in Google Scholar

[51] Kähler CM, Herold M, Wiedermann CJ. Substance P: a competence factor for human fibroblast proliferation that induces the release of growth-regulatory arachidonic acid metabolites. J Cell Physiol. 1993; 156:579–587. http://dx.doi.org/10.1002/jcp.104156031810.1002/jcp.1041560318Search in Google Scholar

[52] Kähler CM, Sitte BA, Reinisch N, Wiedermann CJ. Stimulation of the chemotactic migration of human fibroblasts by substance P. Eur J Pharmacol. 1993; 249:281–286. http://dx.doi.org/10.1016/0014-2999(93)90523-K10.1016/0014-2999(93)90523-KSearch in Google Scholar

[53] Parenti A, Amerini S, Ledda F, Maggi CA, Ziche M. The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture. Naunyn Schmiedebergs Arch Pharmacol. 1996; 353:475–481. http://dx.doi.org/10.1007/BF0016916510.1007/BF00169165Search in Google Scholar

[54] Bae SJ, Matsunaga Y, Takenaka M, Tanaka Y, Hamazaki Y, Shimizu K, Katayama I. Substance P induced preprotachykinin-a mRNA, neutral endopeptidase mRNA and substance P in cultured normal fibroblasts. Int Arch Allergy Immunol. 2002; 127:316–321. http://dx.doi.org/10.1159/00005774910.1159/000057749Search in Google Scholar

[55] Liu JY, Hu JH, Zhu QG, Li FQ, Sun HJ. Substance P receptor expression in human skin keratinocytes and fibroblasts. Br J Dermatol. 2006; 155:657–662. http://dx.doi.org/10.1111/j.1365-2133.2006.07408.x10.1111/j.1365-2133.2006.07408.xSearch in Google Scholar

[56] Kähler CM, Herold M, Reinisch N, Wiedermann CJ. Interaction of substance P with epidermal growth factor and fibroblast growth factor in cyclooxygenase-dependent proliferation of human skin fibroblasts. J Cell Physiol. 1996; 166:601–608. http://dx.doi.org/10.1002/(SICI)1097-4652(199603)166:3<601::AID-JCP15>3.0.CO;2-910.1002/(SICI)1097-4652(199603)166:3<601::AID-JCP15>3.0.CO;2-9Search in Google Scholar

[57] Hu D, Chen B, Zhu X, Tao K, Tang C, Wang J. Substance P up-regulates the TGF-beta 1 mRNA expression of human dermal fibroblasts in vitro. Zhonghua Zheng Xing Wai Ke Za Zhi. 2002; 18:234–236. Search in Google Scholar

[58] Morbidelli L, Maggi CA, Ziche M. Effect of selective tachykinin receptor antagonists on the growth of human skin fibroblasts. Neuropeptides. 1993; 24:335–341. http://dx.doi.org/10.1016/0143-4179(93)90004-T10.1016/0143-4179(93)90004-TSearch in Google Scholar

[59] Xie L, Takahara M, Nakahara T, Oba J, Uchi H, Takeuchi S, Moroi Y, Furue M. CD10-bearing fibroblasts may inhibit skin inflammation by down-modulating substance P. Arch Dermatol Res. 2011;303(1):49–55. http://dx.doi.org/10.1007/s00403-010-1093-910.1007/s00403-010-1093-9Search in Google Scholar

[60] Liu JY, Hu JH, Zhu QG, Li FQ, Wang J, Sun HJ. Effect of matrine on the expression of substance P receptor and inflammatory cytokines production in human skin keratinocytes and fibroblasts. Int Immunopharmacol. 2007; 7(6):816–823. http://dx.doi.org/10.1016/j.intimp.2007.02.00310.1016/j.intimp.2007.02.003Search in Google Scholar

[61] Liu JY, Zhao YZ, Peng C, Li FQ, Zhu QG, Hu JH. Effect of cetirizine hydrochloride on the expression of substance P receptor and cytokines production in human epidermal keratinocytes and dermal fibroblasts. Yao Xue Xue Bao. 2008;43(4):383–387. Search in Google Scholar

[62] Olerud JE, Usui ML, Seckin D, Chiu DS, Haycox CL, Song IS, Ansel JC, Bunnett NW. Neutral endopeptidase expression and distribution in human skin and wounds. J Invest Dermatol. 1999; 112:873–881. http://dx.doi.org/10.1046/j.1523-1747.1999.00596.x10.1046/j.1523-1747.1999.00596.xSearch in Google Scholar

[63] McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 1998; 393:333–339. http://dx.doi.org/10.1038/3066610.1038/30666Search in Google Scholar

[64] Husmann K, Sexton PM, Fischer JA, Born W. Mouse receptor-activity-modifying proteins 1, -2 and -3: amino acid sequence, expression and function. Mol Cell Endocrinol. 2000; 162:35–43. http://dx.doi.org/10.1016/S0303-7207(00)00212-410.1016/S0303-7207(00)00212-4Search in Google Scholar

[65] Chakravarty P, Suthar TP, Coppock HA, Nicholl CG, Bloom SR, Legon S, Smith DM. CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues. Br J Pharmacol. 2000; 130:189–195. http://dx.doi.org/10.1038/sj.bjp.070297510.1038/sj.bjp.0702975Search in Google Scholar

[66] Bailey RJ, Hay DL. Pharmacology of the human CGRP1 receptor in Cos 7 cells. Peptides. 2006; 27:1367–1375. http://dx.doi.org/10.1016/j.peptides.2005.11.01410.1016/j.peptides.2005.11.014Search in Google Scholar

[67] Choksi T, Hay DL, Legon S, Poyner DR, Hagner S, Bloom SR, Smith DM. Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines. Br J Pharmacol. 2002; 136:784–792. http://dx.doi.org/10.1038/sj.bjp.070476110.1038/sj.bjp.0704761Search in Google Scholar

[68] Withers DJ, Coppock HA, Seufferlein T, Smith DM, Bloom SR, Rozengurt E. Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells. FEBS Lett. 1996; 378:83–87. http://dx.doi.org/10.1016/0014-5793(95)01427-610.1016/0014-5793(95)01427-6Search in Google Scholar

[69] Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem. 2000; 275(40):31438–31443. http://dx.doi.org/10.1074/jbc.M00560420010.1074/jbc.M005604200Search in Google Scholar PubMed